<DOC>
	<DOCNO>NCT02180529</DOCNO>
	<brief_summary>Background : The increase life expectancy rise ratio old young people population result increase number suffer decrease cognitive ability , Mild Cognitive Impairment ( MCI ) . Methylphenidate improve cognitive ability , mainly memory executive function . Working hypothesis aim : This study examine effect Ritalin treatment old people suffer MCI . Our hypothesis treatment Ritalin improve cognitive function suffer MCI , especially domains attention executive function . Methods A randomize , double-blind , case-control study . 120 patient old 65 year age diagnose suffer MCI past year geriatric assessment facility Beersheva . Patients randomize equal group either study group ( Ritalin treatment ) control group ( placebo ) . Each participant attend geriatric unit four consecutive day : day prior begin intervention participant undergo cognitive assessment 9:00 . On intervention day ( day 2-4 ) participant undergo cognitive assessment 9:00 morning , follow administration ( 10:30 ) different dos Ritalin ( 10 , 20 30mg ) every day intervention . Participants control group receive placebo . Two hour take drug placebo participant group assess cognitively mean Mindstreams MoCA ( Montreal Cognitive Assessment ) . Expected result : Ritalin treatment improve cognitive function subject , mainly domains concentration executive function</brief_summary>
	<brief_title>The Effects Methylphenidate Cognitive Function Older People With Mild Cognitive Impairment</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>&gt; 65 year old Male Female Living community Suffer unstable condition , example , unstable heart disease , severe heart failure , severe renal failure , cirrhosis , blood pressure 160/100 ; patient suffer glaucoma , hyperthyroididsm , epilepsy , patient stroke , patient Parkinson 's disease , major depression , schizophrenia receive neuroleptic drug ; patient suffer dementia patient recieve treatment acetylcholinesterase inhibitor memantine . know sensitivity methylphenidate .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>methylphenidate , elderly , mild cognitive impairment</keyword>
</DOC>